Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of DP-R208 vs Components in Healthy Volunteers
NCT02707224Phase 1Completed
- Sponsor
- Alvogen
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of candesartan cilexetil + rosuvastatin in hypertension (HTN) and hypercholesterolemia (2 arms), sponsored by Alvogen. Primary endpoints: Peak Plasma Concentration and Area under the plasma concentration versus time curve. Started Jan 2015; status: completed.
02
Drugs
candesartan cilexetil + rosuvastatin
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02707224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707224.